-The Telegraph New Delhi: Patients' rights groups have accused the Centre of trying to use a decade-old programme that delivers inexpensive medicines through government-supported retail outlets to promote the Bharatiya Janata Party (BJP). The Jan Swasthya Abhiyan (JSA) and the All India Drug Action Network (AIDAN) on Monday expressed concern at what they said was the "misuse of the public-funded Pradhanmantri Bharatiya Janaushadhi Pariyojana for the promotion of one political party". They said...
More »SEARCH RESULT
Total Matching Records found : 2200
'Don't share your Aadhaar number', says UIDAI after telecom authority chief's public challenge
-Scroll.in The Aadhaar authority said that sharing the unique ID is not in accordance with the law. The Unique Identification Authority of India on Tuesday issued a statement warning people against sharing their Aadhaar number on social media platforms or elsewhere, and posing challenges to others. The Aadhaar authority said that such activities are in contravention of the law. The warning follows Telecom Regulatory Authority of India chairperson Ram Sewak Sharma’s act...
More »States to supply milk under Mid-Day Meal, Anganwadi schemes
-PTI Move to help farmers, decrease stocks New Delhi: Most states have agreed to supply milk for two days a week through Mid-Day Meal and Anganwadi schemes in order to absorb surplus stock and ensure better prices to farmers, Animal Husbandry and Dairy Secretary Tarun Shridhar said. Farmers are in distress in key milk producing states like Maharasthra because of fall in the procurement rate amid surplus milk production, piling up of skimmed...
More »Rs. 5 lakh-a-day fine warning to Net firms -R Balaji
-The Telegraph New Delhi: The Supreme Court on Friday censured search engines and social networking sites as "irresponsible" for allowing content that provoked lynchings, threatening a Rs 5 lakh-a-day fine till they developed a fool-proof mechanism to weed out such material. Eventually, the bench of Justices Madan B. Lokur and U.U. Lalit granted 30 days to Yahoo, Facebook Ireland, Facebook India, Google India, Google Inc, Microsoft and WhatsApp to install such a...
More »Patent challenge to hepatitis-C medicines
-The Telegraph New Delhi: Patients' rights advocates in India on Tuesday filed two oppositions in the Indian patent office, challenging patent claims by the US pharmaceutical company Gilead Sciences for its medicines sofosbuvir and velpatasvir, used to treat hepatitis-C infections. The oppositions filed by the Delhi Network of Positive People (DNP+) challenge Gilead's patent applications for the tablet formulations of the fixed dose combination of sofosbuvir and velpatasvir and a new form...
More »
